Perspective Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.95

-0.03 (-1.01%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +566.8% upside

Low Target $12.33

Average Target $19.67

High Target $23.14

Current Price $2.95

Current
$2.95

Target
$19.67

$12.33 $19.67 avg $23.14

Scenario Analysis

Bear Case

$12.33

318.0%

Low target

Base Case

$19.67

+566.8%

Avg target

Bull Case

$23.14

+684.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$6.16

-52.1% from high

52-Week Low

$1.96

+50.5% from low

Target vs 52W High

$19.67

+219.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%